These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3953284)

  • 1. [In vitro biopharmaceutical control of pharmaceutical preparations. 7. Design and experimental study of flow through cells applicable to dissolution tests].
    Kissné Csikós E; Keserü P
    Acta Pharm Hung; 1986 Jan; 56(1):26-33. PubMed ID: 3953284
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro biopharmaceutical control of pharmaceutical preparations. 8. Mathematical method for the evaluation of dissolution curves determined in flow-through cells].
    Kissné CE; Keserü P
    Acta Pharm Hung; 1986 Mar; 56(2):65-71. PubMed ID: 3705967
    [No Abstract]   [Full Text] [Related]  

  • 3. Discrepancy among dissolution rates of commercial tablets as a function of dissolution method. Part 5: In vitro/in vivo correlation for chlorpromazine hydrochloride tablets.
    Ammar HO; Khalil RM; Omar SM
    Pharmazie; 1993 Dec; 48(12):932-5. PubMed ID: 8115438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro pharmaceutical control of pharmaceutical preparations. 4. Comparative dissolution and in vitro equivalence study of nitroglycerin tablets].
    Keserü P; Paál T; Török I; Köszeginé Szalai H; Kissné Csikós E
    Acta Pharm Hung; 1985 Jul; 55(4):229-37. PubMed ID: 3931414
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system.
    Möller H; Wirbitzki E
    Boll Chim Farm; 1993 Apr; 132(4):105-15. PubMed ID: 8333916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International harmonization of generic drugs: in vitro dissolution tests for Japanese and American generic tablets.
    Otsuka M; Tomita H; Otsuka K; Kamae I; Jorgenson JA
    Biomed Mater Eng; 2006; 16(2):129-35. PubMed ID: 16477121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in the manufacturing and control of tablets. XII. Determination of drug release from single preparations in the in-vitro experiments].
    Lichnerová I; Chalabala M
    Cesk Farm; 1974 Mar; 23(2):88-93. PubMed ID: 4821802
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro dissolution test of tamoxifen citrate preparations.
    Braga RM; Carvalho RD; Fonseca SG; Strattmann R; De Santana DP; De Albuquerque MM
    Boll Chim Farm; 2001; 140(6):467-70. PubMed ID: 11822241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro biopharmaceutical control of drug preparations. 2. Comparison of various extraction-testing apparatuses with coated tablets containing Aparkazin (diethazine chloride)].
    Keserü P; Varsányi E; Paál T
    Acta Pharm Hung; 1981 Nov; 51(6):264-9. PubMed ID: 6895684
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies on the dissolution rate in vitro of anwei tablets].
    Zhao RT; Fan SZ; Lu FJ
    Zhong Yao Tong Bao; 1987 Oct; 12(10):25-7, 63. PubMed ID: 3449238
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lot-to-lot variation in dissolution of tolbutamide tablets.
    Ayres JW
    Am J Hosp Pharm; 1980 Oct; 37(10):1329-32. PubMed ID: 7424928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro evaluation of nimesulide-containing preparations on the Italian market.
    Butler D; Bonadeo D; Maroni A; Foppoli A; Zema L; Giordano F
    Boll Chim Farm; 2000; 139(6):237-41. PubMed ID: 11213426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling drug dissolution from controlled release products using genetic programming.
    Do DQ; Rowe RC; York P
    Int J Pharm; 2008 Mar; 351(1-2):194-200. PubMed ID: 18053658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of the technological procedure and additives on the dissolution rate and absorption of active ingredients. I. Physical properties of acetylsalicylic acid tablets and of the dissolution rate of the active ingredient].
    Selmeczi B; Kedvessy G; Nagy G; Pintyéné Hódi K; Tencova A; Kiszeleva G
    Acta Pharm Hung; 1981; 51(5):222-7. PubMed ID: 7324971
    [No Abstract]   [Full Text] [Related]  

  • 17. Probability of passing dissolution acceptance criteria for an immediate release tablet.
    Dumont ML; Berry MR; Nickerson B
    J Pharm Biomed Anal; 2007 May; 44(1):79-84. PubMed ID: 17379465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell.
    Motz SA; Schaefer UF; Balbach S; Eichinger T; Lehr CM
    Eur J Pharm Biopharm; 2007 May; 66(2):286-95. PubMed ID: 17156983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
    Breier AR; Paim CS; Steppe M; Schapoval EE
    J Pharm Pharm Sci; 2005 Aug; 8(2):289-98. PubMed ID: 16124939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The importance of micronization in the design of dosage forms I. Theoretical and biopharmaceutical aspects].
    Antal I
    Acta Pharm Hung; 2006; 76(2):95-103. PubMed ID: 17094668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.